Fig. 10.
Survival of AML patients.
Survival rates for patients exhibiting normal (A) or high (B) IL-3Rα levels. Patients with M3 AML were excluded from this analysis because they received different treatment than the rest of AML patients.
Survival of AML patients.
Survival rates for patients exhibiting normal (A) or high (B) IL-3Rα levels. Patients with M3 AML were excluded from this analysis because they received different treatment than the rest of AML patients.
